"Multifactorial Risk Stratification in Acute and Chronic Cardiovascular Disease"
Launched by MEDICAL UNIVERSITY INNSBRUCK · Jul 21, 2022
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Multifactorial Risk Stratification in Acute and Chronic Cardiovascular Disease," is focused on finding better ways to identify patients who are at high risk for serious heart-related conditions. Researchers are working to create models that can help detect issues early in patients with various types of cardiovascular diseases, whether they are short-term (acute) or long-term (chronic). The goal is to improve patient care by catching problems before they become more severe.
To participate in this study, individuals must be at least 18 years old and have either a current or past heart condition related to structural problems, heart rhythm issues, or inflammation. It's important to have informed consent, meaning participants should fully understand the study and agree to join. Unfortunately, pregnant or breastfeeding women cannot participate. Those involved in the trial can expect regular check-ups and assessments that will contribute to the understanding of cardiovascular diseases and help improve future treatments.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Decision-eligible male and female patients ≥18 years of age
- • Acute or chronic condition due to structural, rhythmologic, or inflammatory cardiovascular disease
- • Informed consent for participation in the clinical trial
- Exclusion Criteria:
- • missing infromed consent
- • pregnant or breast-feeding women
About Medical University Innsbruck
The Medical University of Innsbruck is a leading academic institution dedicated to advancing healthcare through innovative research and clinical excellence. Situated in the heart of the Austrian Alps, it combines a rich tradition of medical education with cutting-edge scientific inquiry. As a prominent sponsor of clinical trials, the university focuses on a broad spectrum of medical fields, emphasizing the translation of research findings into practical applications for patient care. With a commitment to ethical standards and rigorous methodologies, the Medical University of Innsbruck strives to enhance treatment options and improve health outcomes globally through its collaborative efforts in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Innsbruck, Tyrol, Austria
Münster, Tyrol, Austria
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials